Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Stocktreeon Oct 05, 2016 4:06pm

80 Views

Post# 25313633

RE:RE:RE:Does anybody know if Spectral ever responds to shareholders?

I would add that we will not have much confidence on what anything management would say at this point. We had a clear picture painted to us that there was every chance we would get good to extraordinary results. So unless they present a detailed analysis of what was observed in the study, who could believe them? And if they do, lawsuit for not having reported their complete data earlier.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?